Temofonte, N., Sajan, M. P., Nimal, S., Pastoor, T., Fumero, C., Casaubon, L., . . . Farese, R. V. (2008). Combined thiazolidinedione–metformin treatment synergistically improves insulin signalling to insulin receptor substrate-1-dependent phosphatidylinositol 3-kinase, atypical protein kinase C and protein kinase B/Akt in human diabetic muscle.

Temofonte, N., M. P. Sajan, S. Nimal, T. Pastoor, C. Fumero, L. Casaubon, J. L. Powe, M. L. Standaert, and R. V. Farese. Combined Thiazolidinedione–metformin Treatment Synergistically Improves Insulin Signalling to Insulin Receptor Substrate-1-dependent Phosphatidylinositol 3-kinase, Atypical Protein Kinase C and Protein Kinase B/Akt in Human Diabetic Muscle. 2008.

Temofonte, N., et al. Combined Thiazolidinedione–metformin Treatment Synergistically Improves Insulin Signalling to Insulin Receptor Substrate-1-dependent Phosphatidylinositol 3-kinase, Atypical Protein Kinase C and Protein Kinase B/Akt in Human Diabetic Muscle. 2008.